MRI versus mammography for breast cancer screening in women with familial risk (FaMRIsc): a multicentre, randomised, controlled trial

Sepideh Saadatmand(Erasmus MC), Edith van Druten(Reinier de Graaf Hospital), Eva V. E. Madsen(Erasmus MC), Margrethe Schlooz-Vries, Huub B W Gort, Emiel J. Rutgers(Oncode Institute), Ingeborg Mares-Engelberts(Franciscus Vlietland), Eric Tetteroo(Medisch Centrum Leeuwarden), Jelle Wesseling(Leiden University Medical Center), Ernest J. T. Luiten(Amphia Ziekenhuis), H. Amarens Geuzinge(Erasmus MC), Marc B. I. Lobbes(Maastricht University Medical Centre), Rob A.�E.�M. Tollenaar(Leiden University Medical Center), Arjen J. Witkamp(University Medical Center Utrecht), Margreet G.E.M. Ausems(McGill University Health Centre), Eveline A.M. Heijnsdijk(Erasmus MC), J. Remmelzwaal, Martin N.J.M. Wasser(Leiden University Medical Center), Wouter B. Veldhuis, Claudette E. Loo(Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital), Joost Rothbarth(Erasmus MC Cancer Institute), Harmien M. Zonderland(Leiden University Medical Center), Roelie Roi-Antonides, Kristien Keymeulen, Mandy M van Rosmalen, Maartje J. Hooning(Erasmus MC Cancer Institute), Ritse M. Mann(Radboud University Nijmegen), Harry J. de Koning(Erasmus MC), Wilma E. Mesker(Leiden University Medical Center), Nico Karssemeijer(Radboud University Nijmegen), Linetta B. Koppert(Erasmus MC Cancer Institute), Cecile de Monyé, Carolien Contant, Jan C. Oosterwijk(University Medical Center Groningen), Madeleine M.A. Tilanus‐Linthorst(Erasmus University Rotterdam), Diderick B. W. de Roy van Zuidewijn(Medisch Centrum Leeuwarden), Martijne van ’t Riet(Reinier de Graaf Hospital), Inge-Marie Obdeijn, Cees Verhoef(Erasmus MC), Suzan van der Meij(Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital)
The Lancet Oncology
June 17, 2019
Cited by 174


Related Papers